Log In
Print
BCIQ
Print
Print this Print this
 

CCX872

  Manage Alerts
Collapse Summary General Information
Company ChemoCentryx Inc.
DescriptionNext-generation oral CC chemokine receptor 2 (CCR2; CD192) antagonist
Molecular Target CC chemokine receptor 2 (CCR2) (CD192)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPancreatic cancer
Indication DetailsTreat non-resectable pancreatic cancer; Treat pancreatic cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today